(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 13.2% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.12%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.59%.
Twist Bioscience's revenue in 2025 is $347,680,000.On average, 4 Wall Street analysts forecast TWST's revenue for 2025 to be $22,548,361,175, with the lowest TWST revenue forecast at $22,466,156,229, and the highest TWST revenue forecast at $22,628,528,971. On average, 4 Wall Street analysts forecast TWST's revenue for 2026 to be $26,661,184,841, with the lowest TWST revenue forecast at $26,372,089,461, and the highest TWST revenue forecast at $26,815,468,905.
In 2027, TWST is forecast to generate $30,925,117,016 in revenue, with the lowest revenue forecast at $30,925,117,016 and the highest revenue forecast at $30,925,117,016.